GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 main protease in complex with PF07321332 in spacegroup P1211

Analyse Crystal structure of SARS-cov-2 main protease in complex with PF07321332 in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7VLP
Type
protein
Length
602 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Replicase polyprotein 1A
UniProt
P0DTC1
Ligands
4WI
Pockets
7 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReplicase polyprotein 1Aprotein30325% helix, 29% strandP0DTC1
BReplicase polyprotein 1Aprotein29927% helix, 30% strandP0DTC1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17820.710.7763empty
22960.570.7753empty
32180.560.7939empty
42080.520.77264WI
52010.510.77264WI

Interfaces

1 interface between chains.

  • A–B · 1058 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7VLP · Crystal structure of SARS-Cov-2 main protease in complex with PF07321332 in spacegroup… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.